Kidney Cancer

Latest News

Belzutifan nears EU approval for advanced renal cell carcinoma
Belzutifan nears EU approval for advanced renal cell carcinoma

December 13th 2024

A final decision on marketing authorization is anticipated for Q1 of 2025.

Phase 1/2 trial launches of CAR T cell therapy for ccRCC
Phase 1/2 trial launches of CAR T cell therapy for ccRCC

November 20th 2024

ALLO-316 shows encouraging CAR activity in advanced ccRCC
ALLO-316 shows encouraging CAR activity in advanced ccRCC

November 8th 2024

Casdatifan demonstrates encouraging clinical activity in renal cell carcinoma
Casdatifan demonstrates encouraging clinical activity in renal cell carcinoma

November 4th 2024

FDA grants Regenerative Medicine Advanced Therapy designation to ALLO-316 for RCC
FDA grants Regenerative Medicine Advanced Therapy designation to ALLO-316 for RCC

October 29th 2024

Latest CME Events & Activities

More News

© 2024 MJH Life Sciences

All rights reserved.